Read the full article PDF Strategies_prolactin
Read More
Fear of falling : efficacy of virtual reality associated with serious games in elderly people. Abstract : OBJECTIVE : AMBULOPHOBIA : Fear of falling is defined as an ongoing concern about falling that is not explained by physical examination. Focusing on the psychological dimension of this […]
Read More
Fluoxetine for Pediatric Patients US FDA Approved for Pediatric Use Major depressive disorder (fluoxetine, ages 8 and older) Obsessive compulsive disorder (fluoxetine, ages 7 and older) Bipolar depression [in combination with olanzapine (Symbyax), ages 10 and older] Off-Label for Pediatric Use But Approved in Adults Panic […]
Read More
As evidence supporting the use of electroconvulsive therapy (ECT) to treat patients with depression and other psychiatric illnesses continues to grow, myths about this treatment persist. In light of these myths, patients might be reluctant to receive ECT. As clinicians, we need to educate patients about […]
Read More
Clozapine What’s of Interest: Clozapine REMS and ANC monitoring update Brands Clozaril, Leponex, Versacloz (oral suspension), Fazaclo ODT (oral disintegrating tablet) Class Atypical antipsychotic (serotonin-dopamine antagonist; second-generation antipsychotic; also a mood stabilizer) Approved For: Treatment-resistant schizophrenia Reduction in risk of recurrent suicidal behavior in patients […]
Read More
What is Epidiolex? Epidiolex is an oral liquid-based drug made from the cannabidiol (CBD) portion of cannabis. Compared to the tetrahydrocannabinol (THC) portion, CBD is not psychoactive, so taking this drug would not result in a high for the user. CBD acts on different parts of […]
Read MoreThe US FDA has approved the first non-opioid treatment for the relief of opioid withdrawal symptoms. The medication, lofexidine hydrochloride (trade name Lucemyra), is an oral, selective alpha-2 adrenergic receptor agonist that reduces the release of norepinephrine, which may lead to relief of autonomic […]
Read More
Prof. Dr. Tarek Assad sums up the difference between synthetic and natural cannabinoids. Aspects of comparison are regarding nature, pharmacology, morbidity …etc. The data were explained within a weekly scientific meeting in the Institute of Psychiatry, Ain Shams University, Jan 17-2017
Read More
To screen for Obstructive Sleep Apnea, we need to check for multiple factors. The STOP-Bang questionnaire looks at these multiple factors. A link to information about the questionnaire is provided below. 1. Snoring Ask the patient and the person who sleeps […]
Read MoreRisperidone (US brand name Risperdal® and generic) is a second-generation (“atypical”) antipsychotic. Here is basic information about this medication. FDA-approved indications 1. Treatment of schizophrenia 2. As monotherapy or adjunctive therapy with lithium or valproate, for the treatment of acute manic or mixed episodes associated with Bipolar I […]
Read More
